SSTR2 and familial hyperinsulinism: Some years ago, somatostatin receptor scintigraphy (Octreoscan/111In-pentetreotide scintigraphy; mainly targets Somatostatin receptor type 2 [SSTR2]) and 18F-DOPA PET were successfully used to detect focal nesidioblastosis [55,111].